# CORRESP — MANGOCEUTICALS, INC.  (MGRX)  (CIK 0001938046)

> <strong>MANGOCEUTICALS, INC.  (MGRX)  (CIK 0001938046) → SEC staff</strong> · filed 2026-01-26 · ticker MGRX · SIC 8090

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-003619
- **Form:** CORRESP
- **Filer:** MANGOCEUTICALS, INC.  (MGRX)  (CIK 0001938046)
- **CIK:** 0001938046
- **Ticker:** MGRX
- **Filed:** 2026-01-26
- **SIC industry:** 8090
- **HQ:** Dallas, TX

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1938046/000149315226003619/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1938046&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for MANGOCEUTICALS, INC.  (MGRX)  (CIK 0001938046)

- UPLOAD — 2026-01-27 — /comment-letter/0000000000-26-000913

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, MANGOCEUTICALS, INC.  (MGRX)  (CIK 0001938046) (CIK 0001938046), filed 2026-01-26, accession 0001493152-26-003619. Retrieved via MORVS 2026-11-16 from https://api.morvs.ai/comment-letter/0001493152-26-003619.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*
